tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tazeen Ahmad, 304 are a BUY (69.09%), 96 are a HOLD (21.82%), 40 are a SELL (9.09%).
Analyst Tazeen Ahmad, currently employed at BAML, carries an average stock price target met ratio of 55.22% that have a potential upside of 29.42% achieved within 148 days.
Tazeen Ahmad’s has documented 864 price targets and ratings displayed on 67 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on FDMT, 4D Molecular Therapeutics at 29-Sep-2026.
Analyst best performing recommendations are on SRZN (SURROZEN).
The best stock recommendation documented was for SRZN (SURROZEN) at 11/17/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.65 (9.91%) receiving and performance score of 99.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jun-2025
$36
$16.88 (88.28%)
$37
10 days ago
(08-Oct-2026)
1/10 (10%)
$16.42 (83.86%)
173
Buy Since 15-Dec-2025
$33
$13.88 (72.59%)
$37
23 days ago
(25-Sep-2026)
0/3 (0%)
$12.32 (59.57%)
Buy Since 17-Apr-2025
$34
$14.88 (77.82%)
$36
23 days ago
(25-Sep-2026)
4/6 (66.67%)
$13.32 (64.41%)
144
Buy Since 25-Sep-2025
$31
$11.88 (62.13%)
$38
23 days ago
(25-Sep-2026)
1/4 (25%)
$10.32 (49.90%)
831
Buy Since 28-Feb-2024
$35
$15.88 (83.05%)
$41
23 days ago
(25-Sep-2026)
9/15 (60%)
$14.32 (69.25%)
393
Which stock is Tazeen Ahmad most bullish on?
Which stock is Tazeen Ahmad most reserved on?
What Year was the first public recommendation made by Tazeen Ahmad?
